Perspective Therapeutics, Inc. (CATX)
3.87
+0.10
(+2.65%)
USD |
NYAM |
May 21, 16:00
3.875
0.00 (0.00%)
After-Hours: 19:59
Perspective Therapeutics Research and Development Expense (TTM) : 77.61M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Plus Therapeutics, Inc. | 9.488M |
| AVITA Medical, Inc. | 20.18M |
| Twist Bioscience Corp. | 71.89M |
| Elutia, Inc. | 5.732M |
| TriSalus Life Sciences, Inc. | 14.88M |